BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6820412)

  • 1. Carrier detection in ornithine transcarbamylase deficiency.
    Haan EA; Danks DM; Grimes A; Hoogenraad NJ
    J Inherit Metab Dis; 1982; 5(1):37-40. PubMed ID: 6820412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic counseling in ornithine carbamoyltransferase deficiency].
    Pelet A; Toumas E; Rabier D; Kaplan J; Kamoun P; Frezal J; Saudubray JM; Munnich A
    Ann Biol Clin (Paris); 1988; 46(7):455-9. PubMed ID: 2903704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new family with mutation of the structural gene of human ornithine carbamoyltransferase].
    Stoll C; Bieth R; Dreyfus J; Flori E; Lutz P; Levy JM
    Arch Fr Pediatr; 1978 May; 35(5):512-8. PubMed ID: 678030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ornithine transcarbamylase deficiency in male adolescence and adulthood.
    Yoshino M; Nishiyori J; Yamashita F; Kumashiro R; Abe H; Tanikawa K; Ohno T; Nakao K; Kaku N; Fukushima H
    Enzyme; 1990; 43(3):160-8. PubMed ID: 2095337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier detection in a partially dominant X-linked disease: ornithine transcarbamylase deficiency.
    Pelet A; Rotig A; Bonaïti-Pellié C; Rabier D; Cormier V; Toumas E; Hentzen D; Saudubray JM; Munnich A
    Hum Genet; 1990 Jan; 84(2):167-71. PubMed ID: 2298453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of ornithine transcarbamylase (OTC) deficiency in small intestine for urinary orotic acid excretion: analysis of OTC-deficient spf-ash mice with OTC transgene.
    Saheki T; Mori K; Kobayashi K; Horiuchi M; Shige T; Obara T; Suzuki S; Mori M; Yamamura K
    Biochim Biophys Acta; 1995 Jan; 1270(1):87-93. PubMed ID: 7827141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The allopurinol loading test in detecting obligate heterozygotes for OCT deficiency.
    Sebesta I; Krijt J; Fairbanks LD; Simmonds HA
    J Inherit Metab Dis; 1994; 17(1):133-4. PubMed ID: 8051924
    [No Abstract]   [Full Text] [Related]  

  • 8. Study of enzyme defect in a case of ornithine transcarbamylase deficiency.
    Qureshi IA; Letarte J; Quellet R
    Diabete Metab; 1978 Dec; 4(4):239-41. PubMed ID: 729890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA analysis of ornithine transcarbamylase deficiency.
    Wendel U; Wilichowski E; Schmidtke J; Bachmann C
    Eur J Pediatr; 1988 May; 147(4):368-71. PubMed ID: 2899508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitfalls in the detection of heterozygosity by allopurinol in a variant form of ornithine carbamoyltransferase deficiency.
    Barshop BA; Nyhan WL; Climent C; Rubio V
    J Inherit Metab Dis; 2001 Aug; 24(4):513-4. PubMed ID: 11596657
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of ornithine transcarbamylase deficiency heterozygotes by measuring of urinary uracil.
    Sumi S; Matsuura T; Kidouchi K; Togari H; Kubota M; Kitou O; Mikami H; Ohura T; Matsuda I; Wada Y
    Int J Mol Med; 2000 Aug; 6(2):177-80. PubMed ID: 10891562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ornithine transcarbamylase variant in a male patient.
    Stöckler S; Grossschädl F; Bachmann C; Roscher A
    J Inherit Metab Dis; 1987; 10(3):272. PubMed ID: 3123789
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of protein loading tests to identify heterozygosity for ornithine carbamoyltransferase deficiency.
    Becroft DM; Barry DM; Webster DR; Simmonds HA
    J Inherit Metab Dis; 1984; 7(4):157-9. PubMed ID: 6441862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How reliable is the allopurinol load in detecting carriers for ornithine transcarbamylase deficiency?
    Grünewald S; Fairbanks L; Genet S; Cranston T; Hüsing J; Leonard JV; Champion MP
    J Inherit Metab Dis; 2004; 27(2):179-86. PubMed ID: 15159648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allopurinol-induced orotidinuria. A test for mutations at the ornithine carbamoyltransferase locus in women.
    Hauser ER; Finkelstein JE; Valle D; Brusilow SW
    N Engl J Med; 1990 Jun; 322(23):1641-5. PubMed ID: 2342523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel missense mutation in the exon containing the putative ornithine-binding domain of the OTC enzyme in a female.
    Demmer LA; Kim JM; de Martinville B; Dowton SB
    Hum Mutat; 1996; 7(3):279. PubMed ID: 8829665
    [No Abstract]   [Full Text] [Related]  

  • 17. Single-strand conformational polymorphism and direct sequencing applied to carrier testing in families with ornithine transcarbamylase deficiency.
    Tsai MY; Holzknecht RA; Tuchman M
    Hum Genet; 1993 May; 91(4):321-5. PubMed ID: 8099056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humanized liver mouse model with transplanted human hepatocytes from patients with ornithine transcarbamylase deficiency.
    Sugahara G; Yamasaki C; Yanagi A; Furukawa S; Ogawa Y; Fukuda A; Enosawa S; Umezawa A; Ishida Y; Tateno C
    J Inherit Metab Dis; 2021 May; 44(3):618-628. PubMed ID: 33336822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier detection in ornithine transcarbamylase deficiency.
    Hokanson JT; O'Brien WE; Idemoto J; Schafer IA
    J Pediatr; 1978 Jul; 93(1):75-8. PubMed ID: 650350
    [No Abstract]   [Full Text] [Related]  

  • 20. Transient hyperammonemia during aging in ornithine transcarbamylase-deficient, sparse-fur mice.
    Gushiken T; Yoshimura N; Saheki T
    Biochem Int; 1985 Nov; 11(5):637-43. PubMed ID: 4091843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.